CLEAR Harmony 1002-040
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER LONG-TERM SAFETY AND TOLERABILITY STUDY OF ETC-1002 IN PATIENTS WITH HYPERLIPIDEMIA AT HIGH CARDIOVASCULAR RISK WHO ARE NOT ADEQUATELY CONTROLLED BY THEIR LIPID-MODIFYING THERAPY
- Stage
- klaar
- Medicine
- ETC-1002
- Population
- Primaire preventie coronairlijden
- Phase
- III
- First Patient In
- 1 September 2016
- Last Patient In
- 20 April 2017
- Last Patient Last Visit
- 21 February 2018
Study Director
